GLEN ALLEN, Va.--(BUSINESS WIRE)--Nephrocor™ announces immediate availability of RenalVysion™, the next-generation non-invasive urine-based test for early diagnosis of kidney disease. RenalVysion™ identifies and measures urinary sediment findings not detected in routine urinalysis. These highly specific results allow anatomic localization of injury in the kidney and the severity of disease.
